Form 8-K - Current report:
SEC Accession No. 0001193125-25-129488
Filing Date
2025-05-28
Accepted
2025-05-28 16:11:41
Documents
23
Period of Report
2025-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d918164d8k.htm   iXBRL 8-K 44448
2 EX-4.2 d918164dex42.htm EX-4.2 259553
3 EX-4.5 d918164dex45.htm EX-4.5 257607
4 EX-4.7 d918164dex47.htm EX-4.7 332438
5 EX-4.8 d918164dex48.htm EX-4.8 254990
6 EX-5.1 d918164dex51.htm EX-5.1 20161
7 EX-5.2 d918164dex52.htm EX-5.2 15165
8 EX-5.3 d918164dex53.htm EX-5.3 46770
12 GRAPHIC g918164dsp192.jpg GRAPHIC 10942
13 GRAPHIC g918164g0528040536253.jpg GRAPHIC 14158
14 GRAPHIC g918164g0528040536460.jpg GRAPHIC 4965
15 GRAPHIC g918164g0528043114476.jpg GRAPHIC 2910
  Complete submission text file 0001193125-25-129488.txt   1660714

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA teva-20250528.xsd EX-101.SCH 2877
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20250528_lab.xml EX-101.LAB 17167
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20250528_pre.xml EX-101.PRE 10806
26 EXTRACTED XBRL INSTANCE DOCUMENT d918164d8k_htm.xml XML 3614
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 25995538
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)